Recruiting
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
NCT06248515
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
- Locations
-
- Stanford Cancer Institute Palo Alto, California, United States
- Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States